Merck opens manufacturing facility in North Carolina
Merck Opens Vaccine Manufacturing Facility in North Carolina
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. Drugmakers have been exploring the possibility of government-granted exemptions for domestically manufactured medicines since Trump has threatened to impose 25% tariff on pharmaceutical imports.
With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
Achieves ISO9001, EFfCI GMP, and EXCiPACT certifications for its new manufacturing plant.
Gattefossé, a leading provider of specialty ingredients and formulation solutions for personal care and pharmaceutical ...
As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...
ABUJA, NIGERIA / ACCESS Newswire / March 11, 2025 / In a landmark effort to transform Nigeria's pharmaceutical industry and ...
Pharmacists in Nigeria have revealed that low investment and interest in drug and vaccine manufacturing persist because ...
With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback